InvestWiserSimris Alg AB (publ)
SIMRIS-B · Nasdaq Stockholm · Healthcare
0.11SEK
−5.2%last day
Price as of 2 October 2026
Performance
1 month
+13.6%
1 year
−10.6%
3 years, per year
−23.2%
5 years, per year
−29.2%
Largest fall, 3 years
−93.6%
Below the peak now
−98.9%
Volatility, 1 year
160.9%
Return with dividends reinvested.
Key figures
P/E
negative earnings
P/B
186.8
Dividend yield
0.0%
Return on equity
−492.2%
Net margin
–
Market value
15 m USD
Quality, value and trend
Where Simris Alg stands against every Nordic stock today. 100 is best.
17
Profitability and a sound balance sheet over time. Better than 17% of Nordic stocks.
1
The price measured against earnings, assets and cash flow. Better than 1% of Nordic stocks.
74
The price development over the past year. Better than 74% of Nordic stocks.
15
Quality, value and trend together. Better than 15% of Nordic stocks.
About Simris Alg
Simris Alg AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 5 employees.
Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria. It also offers cosmetics and skincare products; biopharmaceuticals; and dietary supplements. The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.
See the full analysis in InvestWiser.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
See the full analysis